The lawsuit comes as the FTC readies litigation against the three largest PBMs for a host of anticompetitive practices that distort the prescription drug market in favor of drug middlemen at the ...

CVS trades below 9x forward PE, indicating it’s priced for further deterioration, but historically and relatively cheap vs.

OPINION - Patients rely on the quality care services provided by pharmacists and pharmacies. On behalf of pharmacies and the ...

Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.

AHF knows all too well how the big three PBM/health insurance mega firms treat independent pharmacies. By design, PBMs force AHF patients out of our custom HIV-care model and into mandatory mail ...

Chains and independent pharmacies alike are short-staffed, leading to long lines and frustrating experiences. Here's why ...

If a pharmacy doesn’t like the prices a PBM offers, they can say no to the contract—but then they’ll likely lose the business, which means they won’t be able to offer prescription drug ...

Eminent business & pharmacy executive takes helm as company ... His innovative approach to pharmacy benefit management has garnered national recognition, positioning Navitus as a leader in the ...